CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
Stereotactic radiationradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01859221
NCT01859221N/ACompleted
CompareCT.gov

Phase II Stereotactic Body Radiotherapy (SBRT) and Stereotactic Hypofractionated Radiotherapy (SHRT) for Oligometastatic Prostate Cancer

University of Florida·interventional·Posted May 21, 2013·Updated Sep 14, 2022

In Brief

A clinical study evaluating Stereotactic radiation for Oligometastatic Prostate Cancer. Completed, enrolled 39 participants across 1 site.

Detailed Summary

The purpose of this phase II study is to evaluate the outcomes of patients treated with an investigational radiation regimen using stereotactic radiotherapy for oligometastatic prostate cancer and to establish efficacy (producing a desired result or effect) and safety in this setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOligometastatic Prostate Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 21, 2013
Enrollment StartMay 1, 2013
Primary CompletionSep 13, 2022
TodayJul 2, 2026
Enrollment to primary: 9.4 yearsPosted 13.1 years ago

Interventions

Stereotactic radiationradiation

Stereotactic radiation